These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 629275

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies of the erythron.
    Pollycove M, Tono M.
    Semin Nucl Med; 1975 Jan; 5(1):11-61. PubMed ID: 1118735
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Membrane components in the red cells of patients with sickle cell anemia. Relationship to cell aging and to irreversibility of sickling.
    Westerman MP, Diloy-Puray M, Streczyn M.
    Biochim Biophys Acta; 1979 Oct 19; 557(1):149-55. PubMed ID: 549632
    [Abstract] [Full Text] [Related]

  • 9. Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation.
    Deiderich DA, Trueworthy RC, Gill P, Cader AM, Larsen WE.
    J Clin Invest; 1976 Sep 19; 58(3):642-53. PubMed ID: 956392
    [Abstract] [Full Text] [Related]

  • 10. Red cell life span in sickle cell trait.
    Barbedo MM, McCurdy PR.
    Acta Haematol; 1974 Sep 19; 51(6):339-43. PubMed ID: 4212308
    [No Abstract] [Full Text] [Related]

  • 11. The irreversibly sickled cell; a determinant of haemolysis in sickle cell anaemia.
    Serjeant GR, Serjeant BE, Milner PF.
    Br J Haematol; 1969 Dec 19; 17(6):527-33. PubMed ID: 5362290
    [No Abstract] [Full Text] [Related]

  • 12. Kinetic studies of 51Cr and DF32P labelled granulocytes.
    Dresch C, Najean Y, Bauchet J.
    Br J Haematol; 1975 Jan 19; 29(1):67-80. PubMed ID: 1201203
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Estimation of transfused red cell survival using an enzyme-linked antiglobulin test.
    Kickler TS, Smith B, Bell W, Drew H, Baldwin M, Ness PM.
    Transfusion; 1985 Jan 19; 25(5):401-5. PubMed ID: 4049483
    [Abstract] [Full Text] [Related]

  • 19. The irreversibly sickled cell.
    Smith CM, Krivit W, White JG.
    Am J Pediatr Hematol Oncol; 1982 Jan 19; 4(3):307-15. PubMed ID: 7149169
    [Abstract] [Full Text] [Related]

  • 20. Effects of valinomycin, A23187 and repetitive sickling on irreversible sickle cell formation.
    Westerman MP, Allan D.
    Br J Haematol; 1983 Mar 19; 53(3):399-409. PubMed ID: 6402002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.